Capital Advantage’s Abbott ABT Stock Holding History
Bought
Maintained
Sold
Other funds holding ABT
WT
RG
DC
ATO
Capital Advantage's ABT Position: Q2 2026 in Review
Capital Advantage reduced its Abbott (ABT) stake by 20% in Q2 2026, selling an estimated $91.3K and leaving 4,056 shares worth $368K. The position accounts for 0.04% of the portfolio, ranked #111.
Capital Advantage first reported a position in ABT in Q2 2015 and has held it in 18 quarters since. The position peaked at $695K in Q2 2025. 1,385 funds tracked by Wall St. Rank hold ABT as of Q2 2026.
- Capital Advantage held 4,056 shares of Abbott worth $368K as of Q2 2026.
- Capital Advantage sold 1,000 Abbott shares in Q2 2026, an estimated $91.3K.
- Abbott made up 0.04% of Capital Advantage's portfolio in Q2 2026, its #111 holding.
- Capital Advantage first reported a position in Abbott in Q2 2015 and has held it in 18 quarters since.
- Capital Advantage's Abbott position peaked at $695K in Q2 2025.
- 1,385 funds tracked by Wall St. Rank held Abbott as of Q2 2026.
Based on Capital Advantage's 13F filing for Q2 2026, filed 13 Jul 2026.